Neural Network-Based Model Shows Potential to Decrease SLN Biopsy Rate, Costs in Melanoma Subtypes - The Cardiology Advisor


7/21/2022 12:00:00 AM2 years 9 months ago

A decision-analytic study sought to identify an effective model for predicting risk for SLN biopsy and metastasis in patients with cutaneous melanoma.

A neural network-based model was found to be an effective risk stratifying approach for patients with T1b melanoma. These findings were published in JAMA Dermatology. The National Comprehensive Care… [+2099 chars]

full article...